Variant report
Variant | nsv608310 |
---|---|
Chromosome Location | chr7:118926390-118973152 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73221173 | chr7:118927876-118927877 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs115734151 | chr7:118927911-118927912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551019992 | chr7:118927990-118927991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567785968 | chr7:118928060-118928061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536808089 | chr7:118928104-118928105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138431680 | chr7:118928114-118928115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567165261 | chr7:118928116-118928117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190486108 | chr7:118928162-118928163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528405989 | chr7:118928165-118928166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142777312 | chr7:118928179-118928180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs183701418 | chr7:118928210-118928211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536766680 | chr7:118928216-118928217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs308177 | chr7:118928231-118928232 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs573762458 | chr7:118928277-118928278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542403750 | chr7:118928281-118928282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187089044 | chr7:118928291-118928292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572779314 | chr7:118928319-118928320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78851089 | chr7:118928342-118928343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs539612793 | chr7:118952214-118952215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs367788689 | chr7:118952275-118952276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556045677 | chr7:118952280-118952281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576291771 | chr7:118952329-118952330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs541732061 | chr7:118952332-118952333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561765623 | chr7:118952401-118952402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572094274 | chr7:118952428-118952429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs371310147 | chr7:118952446-118952447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs77682931 | chr7:118952457-118952458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370834315 | chr7:118952460-118952461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564234068 | chr7:118952463-118952464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574194042 | chr7:118952565-118952566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533387783 | chr7:118952619-118952620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs191405722 | chr7:118952621-118952622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs563683962 | chr7:118952673-118952674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529611688 | chr7:118952677-118952678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183765181 | chr7:118952739-118952740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549377913 | chr7:118952747-118952748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs114452749 | chr7:118952749-118952750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs374214560 | chr7:118952771-118952772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187759480 | chr7:118952783-118952784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547555528 | chr7:118952787-118952788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560750780 | chr7:118952795-118952796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs199964686 | chr7:118965064-118965065 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs376402585 | chr7:118965072-118965073 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181871282 | chr7:118965106-118965107 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186426957 | chr7:118965287-118965288 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545794985 | chr7:118965292-118965293 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147432237 | chr7:118965347-118965348 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576143409 | chr7:118965365-118965366 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs140686922 | chr7:118965366-118965367 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs201247182 | chr7:118970615-118970616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Schizophrenia | 21346763 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:118927800-118928400 | Enhancers | Fetal Brain Male | brain |
2 | chr7:118952200-118952800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr7:118965000-118965200 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr7:118965200-118965400 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr7:118970600-118971000 | Enhancers | Brain Substantia Nigra | brain |